Bile pigments in emergency and critical care medicine.


Journal

European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857

Informations de publication

Date de publication:
29 Oct 2022
Historique:
received: 24 08 2022
accepted: 20 10 2022
entrez: 30 10 2022
pubmed: 31 10 2022
medline: 2 11 2022
Statut: epublish

Résumé

Bile pigments, such as bilirubin and biliverdin, are end products of the heme degradation pathway in mammals and are widely known for their cytotoxic effects. However, recent studies have revealed that they exert cytoprotective effects through antioxidative, anti-inflammatory, and immunosuppressive properties. All these mechanisms are indispensable in the treatment of diseases in the field of emergency and critical care medicine, such as coronary ischemia, stroke, encephalomyelitis, acute lung injury/acute respiratory distress syndrome, mesenteric ischemia, and sepsis. While further research is required before the safe application of bile pigments in the clinical setting, their underlying mechanisms shed light on their utilization as therapeutic agents in the field of emergency and critical care medicine. This article aims to summarize the current understanding of bile pigments and re-evaluate their therapeutic potential in the diseases listed above.

Identifiants

pubmed: 36309733
doi: 10.1186/s40001-022-00863-0
pii: 10.1186/s40001-022-00863-0
pmc: PMC9618204
doi:

Substances chimiques

Bile Pigments 0
Biliverdine O9MIA842K9
Antioxidants 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

224

Informations de copyright

© 2022. The Author(s).

Références

Immunol Res. 2010 Jul;47(1-3):123-33
pubmed: 20087684
Tokai J Exp Clin Med. 1995 May;20(1):9-16
pubmed: 8869449
Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G695-703
pubmed: 16537973
Arch Toxicol. 2017 Apr;91(4):1847-1858
pubmed: 27578021
Sci Transl Med. 2020 Feb 12;12(530):
pubmed: 32051225
Chest. 1994 May;105(5):1516-27
pubmed: 8181346
Am J Physiol Heart Circ Physiol. 2000 Feb;278(2):H643-51
pubmed: 10666097
Int J Mol Med. 2019 Mar;43(3):1356-1372
pubmed: 30664169
J Pediatr Gastroenterol Nutr. 2002 Sep;35(3):344-9
pubmed: 12352525
Am J Respir Crit Care Med. 2002 Feb 1;165(3):406-11
pubmed: 11818329
Surgery. 2003 Aug;134(2):285-92
pubmed: 12947331
Curr Opin Lipidol. 2015 Oct;26(5):384-7
pubmed: 26339767
J Mol Cell Cardiol. 2014 Aug;73:26-33
pubmed: 24657720
Eur J Cardiothorac Surg. 2014 Mar;45(3):481-8
pubmed: 23946500
J Immunol. 2008 Aug 1;181(3):1887-97
pubmed: 18641326
Clin Pharmacol Ther. 2010 Feb;87(2):187-90
pubmed: 19956091
Surgery. 2022 Nov;172(5):1522-1528
pubmed: 36088170
J Am Heart Assoc. 2021 Oct 19;10(20):e021212
pubmed: 34622671
PLoS One. 2013 May 07;8(5):e63606
pubmed: 23667646
J Zhejiang Univ Sci B. 2007 Jan;8(1):60-9
pubmed: 17173364
N Y State J Med. 1991 Nov;91(11):493-6
pubmed: 1781871
Front Physiol. 2014 Feb 18;5:53
pubmed: 24600401
Pediatrics. 1970 Jan;45(1):102-4
pubmed: 5410230
Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1786-95
pubmed: 16020746
Angew Chem Int Ed Engl. 2016 Jun 20;55(26):7460-3
pubmed: 27144463
Dev Med Child Neurol. 2017 Mar;59(3):297-303
pubmed: 27718221
Semin Fetal Neonatal Med. 2015 Feb;20(1):20-25
pubmed: 25524299
Sci Transl Med. 2021 May 19;13(594):
pubmed: 34011630
Gastroenterology. 2004 Aug;127(2):595-606
pubmed: 15300591
Brain Res. 2008 Jan 10;1188:1-8
pubmed: 18035335
Biochem Med. 1981 Aug;26(1):8-11
pubmed: 7295306
Eur J Cardiothorac Surg. 2012 Dec;42(6):1035-41
pubmed: 22648925
J Pediatr Surg. 2001 Dec;36(12):1764-7
pubmed: 11733902
J Control Release. 2021 Mar 10;331:74-84
pubmed: 33450316
J Biol Chem. 2002 May 17;277(20):17950-61
pubmed: 11880364
Circulation. 2005 Jul 26;112(4):587-91
pubmed: 16027253
Nat Chem Biol. 2005 Sep;1(4):188-9
pubmed: 16408030
Front Cell Dev Biol. 2019 Aug 07;7:154
pubmed: 31448275
Chem Biol Interact. 2001 Jul 31;137(1):59-74
pubmed: 11518564
J Am Heart Assoc. 2018 May 2;7(10):
pubmed: 29720501
Int J Cancer. 2007 Dec 1;121(11):2567-74
pubmed: 17683071
Cell Cycle. 2007 Jan 1;6(1):39-43
pubmed: 17245120
Am J Physiol Gastrointest Liver Physiol. 2002 Jan;282(1):G145-55
pubmed: 11751168
J Biol Chem. 1999 Apr 16;274(16):10852-62
pubmed: 10196162
J Cell Mol Med. 2006 Jul-Sep;10(3):650-71
pubmed: 16989726
Free Radic Biol Med. 2000 Jan 15;28(2):289-309
pubmed: 11281297
Vascul Pharmacol. 2019 Jan;112:79-90
pubmed: 30213580
Am J Respir Cell Mol Biol. 2002 Dec;27(6):739-45
pubmed: 12444034
Am J Transplant. 2005 Feb;5(2):282-91
pubmed: 15643987
Redox Biol. 2019 Sep;26:101284
pubmed: 31400697
JACC Basic Transl Sci. 2018 Aug 01;3(4):464-480
pubmed: 30175270
Apoptosis. 2007 May;12(5):877-85
pubmed: 17294083
PLoS One. 2013 Nov 08;8(11):e80521
pubmed: 24255720
Crit Rev Clin Lab Sci. 2018 Mar;55(2):129-139
pubmed: 29390925
Front Pharmacol. 2019 Jul 24;10:825
pubmed: 31396090
Int J Biochem Cell Biol. 2002 Mar;34(3):216-20
pubmed: 11849989
Science. 1987 Feb 27;235(4792):1043-6
pubmed: 3029864
Am J Physiol Lung Cell Mol Physiol. 2005 Dec;289(6):L1131-7
pubmed: 16155084
Int J Mol Sci. 2021 Jul 31;22(15):
pubmed: 34361019
Arterioscler Thromb Vasc Biol. 2020 Feb;40(2):437-445
pubmed: 31801373
Arch Toxicol. 1991;65(2):81-94
pubmed: 1711838
Basic Res Cardiol. 2017 Jul;112(4):39
pubmed: 28534119

Auteurs

Mizuki Seya (M)

Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-Cho, Kita-Ku, Okayama, 700-8558, Japan.

Toshiyuki Aokage (T)

Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-Cho, Kita-Ku, Okayama, 700-8558, Japan. t_aokage@okayama-u.ac.jp.

Tsuyoshi Nojima (T)

Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-Cho, Kita-Ku, Okayama, 700-8558, Japan.

Atsunori Nakao (A)

Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-Cho, Kita-Ku, Okayama, 700-8558, Japan.

Hiromichi Naito (H)

Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-Cho, Kita-Ku, Okayama, 700-8558, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH